RET and medullary thyroid gland carcinoma: Moreover, the clinical data from both families suggest a trend towards an earlier age at diagnosis of MTC in the RET-G691S/S891A carriers irrespectively of the cis or trans presentation of the RET-S891A mutation and the RET-G691S polymorphism (Additional file 1: Figure S1B).